Information Provided By:
Fly News Breaks for April 28, 2017
ALGN
Apr 28, 2017 | 08:54 EDT
As reported previously, Baird analyst Jeff Johnson upgraded Align Technology to Outperform from Neutral citing its many growth levers and many data points suggesting a new level of acceptance for clear aligner therapy. Johnson said the company's revenue acceleration feels like it has staying power, suggesting the stock could trade in historical ranges reserved for preeminent medtech growers. Johnson raised his price target to $155 from $105 on Align Technology shares.
News For ALGN From the Last 2 Days
There are no results for your query ALGN